Clinical and genetic features of lysinuric protein intolerance in Japan
Authors:
- 8 June 2016
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 58 (10) , 979-983
Abstract
Background: Lysinuric protein intolerance (LPI) is a rare autosomal recessive disorder affecting the transport of cationic amino acid caused by mutations in solute carrier family 7 amino acid transporter light chain, y+L system, member 7 (SLC7A7). This disorder occurs worldwide, especially in Finland and Japan, where founder effect mutations have been reported. Detailed features of the clinical symptoms and mutation types in Japanese LPI, however, remain unclear to date.Methods: An epidemiological nationwide survey of LPI patients was carried out via mail to all domestic university and general hospitals in Japan. Next, the clinical information for each LPI patient was obtained, in the form of a questionnaire, from the attending physicians who replied to the letters.Results: We received answered questionnaires for 43 LPI patients in 19 hospitals. We selected 35 patients who were genetically diagnosed with LPI. The most common clinical manifestations were with protein aversion, ferritinemia, increased serum lactate dehydrogenase, and hyperammonemia. The most frequent SLC7A7 mutation in Japanese LPI patients is p.R410*, which is a founder effect mutation in northern Japan. In total, nine types of mutation were detected in this survey, six of which (p.R410*, p.S238F, c.1630delC, p.S489P, c.1673delG, and IVS3‐IVS5del9.7 kb) have not been reported in other countries.Conclusion: The clinical and genetic features of 35 Japanese patients with LPI were characterized, and no correlation between genotype and phenotype was observed. The importance of early diagnosis for better prognosis of LPI is emphasized.Keywords
This publication has 12 references indexed in Scilit:
- The SLC3 and SLC7 families of amino acid transportersMolecular Aspects of Medicine, 2013
- Lysinuric protein intolerance (LPI): A multi organ disease by far more complex than a classic urea cycle disorderMolecular Genetics and Metabolism, 2012
- Lysinuric protein intolerance: Reviewing concepts on a multisystem diseaseAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- Lysinuric protein intolerance: update and extended mutation analysis of theSLC7A7 geneHuman Mutation, 2007
- Five novelSLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intoleranceHuman Mutation, 2002
- A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effectHuman Mutation, 2000
- SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance familiesHuman Mutation, 2000
- Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance geneNature Genetics, 1999
- SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intoleranceNature Genetics, 1999
- Longitudinal Standards for Height and Height Velocity for Japanese Children from Birth to MaturityClinical Pediatric Endocrinology, 1992